Search clinical trials for: Bromfenac (Xibrom)

Total 91 results

Bp Consulting, Inc

Completed

Randomized, Double Blind Trial of Bromfenac BID (0.09%) as an Adjunct to Argon Laser Therapy in the Treatment of Diabetic Macular Edema.

Diabetic Macular Edema

United States
Johns Hopkins University

Withdrawn

Pilot Study of the Effect of Topical Bromfenac Ophthalmic Solution 0.09%in Patients With Acute Post-operative Cystoid Macular Edema.

Cystoid Macular Edema

United States
Bp Consulting, Inc

Completed

Evaluation of Comfort With Xibrom (Bromfenac Ophthalmic Solution)0.09% and Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Following Selective Laser Trabeculoplasty (SLT)

Intraocular Pressure

United States
Sun Pharmaceutical Industries Limited

Completed

Study to Compare Differing Dosing Regimens of ISV-303 (Bromfenac in DuraSite) to Xibrom and Vehicle in Post Cataract Surgery Volunteers

Ocular Inflammation
Frank A. Bucci, Jr., M.D.
Allergan

Completed

A Comparison of Peak Aqueous Penetration of Acuvail (Ketorolac 0.45%), Xibrom (Bromfenac 0.09%), and Nevanac (Nepafenac 0.1%)in Patients Undergoing Phacoemulsification

Cataracts

United States
Bp Consulting, Inc

Completed

Comparing Optical Coherence Tomography (OCT) and Visual Acuity Outcomes in Subjects Undergoing Cataract Surgery, Who Receive Xibrom Ophthalmic Solution and Standard Presurgical Care vs. Xibrom Ophthalmic Solution Plus Prednisolone Acetate 1% and Standard Presurgical Care

Cataracts

United States
Center For Excellence In Eye Care

Completed

Bromfenac BID Plus Prednisolone Acetate BID Versus Bromfenac BID Plus Prednisolone QID for the Prevention of Cystoid Macular Edema and Retinal Thickening

Cystoid Macular Edema, | Retinal Thickening

United States
Innovative Medical

Completed

Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients: Trough Drug Effects

Cataract

United States
University of Zurich

Completed

vibroX-training in Endurance Trained Men

Health Behavior

Switzerland
Bausch & Lomb Incorporated

Completed

A Dose Ranging Study to Evaluate Safety and Efficacy of Bromfenac Ophthalmic Solution in Dry Eye Disease

Dry Eye Syndrome

United States
Frank A. Bucci, Jr., M.D.
Allergan

Completed

A Comparison of Prostaglandin E2 (PGE2) Inhibition of Acuvail(Ketorolac 0.45%), Xibrom (Bromfenac 0.09%)and Nevanac (Nepafenac)in Patients Undergoing Phacoemulsification

Cataracts
Melissa Toyos
Bausch & Lomb Incorporated

Completed

Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery (QD)

Inflammation | Cataract | Retinal Edema

United States
Seoul National University Hospital

Recruiting

Bromfenac Sodium Hydrate Eye Drops in Familial Exudative Vitreoretinopathy

Familial Exudative Vitreoretinopathies

Korea, Republic of
Kyungpook National University Hospital

Completed

Pseudophakic Cystoid Macular Lesions After Uncomplicated Standard Phacoemulsification

Pseudophakic Cystoid Macular Lesions After Uncomplicated Standard Phacoemulsification
Laboratorios Sophia S.A de C.V.

Completed

Efficacy and Safety of PRO-155 on Inflammation of the Conjunctival Surface in Subjects With Grade I-III Pterygium vs Placebo. (PRO-155/IV)

Ocular Inflammation | Ocular Pain | Pterygium | Post-surgical Inflammation

Mexico
Bausch & Lomb Incorporated

Completed

Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery

Pain | Inflammation | Cataract

United States
Bausch & Lomb Incorporated

Completed

Efficacy and Safety of Bromfenac Ophthalmic Solution

Cataract Surgery

United States
Ophthalmic Consultants of Boston
Bausch & Lomb Incorporated

Unknown

Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic Macular Edema (DME) Refractory to Laser

Diabetic Macular Edema

United States
Bausch & Lomb Incorporated

Completed

Safety and Efficacy of an Ophthalmic Solution in Dry Eye Disease

Dry Eye Disease

United States
Bausch & Lomb Incorporated

Completed

Efficacy Study of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery

Pain | Inflammation

United States
Bausch & Lomb Incorporated

Completed

Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery

Cataract

United States
University of Minnesota

Recruiting

Usability of Vibro-tactile Stimulation to Treat Spasmodic Dysphonia

Spasmodic Dysphonia | Laryngeal Dystonia

United States
Bausch & Lomb Incorporated

Completed

Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery

Pain | Inflammation

United States
Hospital Universitari Vall d'Hebron Research Institute
Universitat Autonoma de Barcelona; Ministerio de Ciencia e Innovación, Spain

Not yet recruiting

Cost-utility and Immuno-inflammatory Effects of the FIBROWALK in Patients With Fibromyalgia (the On&Out Study) (On&Out)

Fibromyalgia

Spain
Sun Yat-sen University
Ministry of Health, China

Completed

Topical 0.1% Bromfenac Sodium and Prostaglandin E2 Inhibition in Cataract Surgery

Cataract

China
Toyos Clinic
Bausch & Lomb Incorporated

Completed

Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1%

Inflammation | Pseudophakia
Innovative Medical

Completed

Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients

Cataract

United States
Babasaheb Ambedkar Memorial Hospital

Completed

Comparison of Treatments in Diabetic Macular Edema

Diabetic Macular Edema
Florida Eye Microsurgical Institute
Bausch & Lomb Incorporated

Completed

Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase

Dry Eye Disease | Ocular Comfort

United States
Agnes Sturma
University of Applied Sciences Upper Austria

Unknown

Vibro-tactile Pressure Feedback of the Prosthetic Foot for Trans-tibial Amputees

Amputation
National University of Science and Technology,...
Higher Education Commission (Pakistan); Family Health Hospital Islamabad Pakistan

Completed

Application of Vibration Wave Therapy to the Children Suffering From Cerebral Palsy and Tongue Spastic Dysarthria

Cerebral Palsy | Spastic Dysarthria

Pakistan
Innovative Medical

Completed

Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%

Vitrectomy

United States
Hospital de La Luz

Unknown

Topical Bromfenac for Intraoperative Miosis and Pain Reduction

Cataract

Mexico
Bucci Laser Vision Institute
Allergan

Completed

A Comparison of Post Phacoemulsification Aqueous Flare in Patients Using Ketorolac 0.45% 2 Times Daily (BID) and Bromfenac 0.09% 2 Times Daily (BID)

Post Operative Anterior Chamber Inflammation (Flare)

United States
University of Minnesota

Not yet recruiting

Laryngeal Vibro-tactile Stimulation as a Non-invasive Symptomatic Treatment for Spasmodic Dysphonia

Adductor Spasmodic Dysphonia | Laryngeal Dystonia | Abductor Spastic Dysphonia

United States
University of Bern

Not yet recruiting

Volumetric Dimensional Changes After Surgical Pontic Site Development Procedures With Connective Tissue Graft or Collagen Matrix

Connective Tissue Graft | Volume Collagen Matrix Xenograft

Switzerland
Oregon Health and Science University
Genentech, Inc.

Completed

Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular Degeneration

Age-Related Macular Degeneration

United States
University of Pisa

Recruiting

Clinical Outcomes of Immediate Implants With or Without a Volume-stable Collagen Matrix

Edentulous Alveolar Ridge

Italy
Bp Consulting, Inc

Completed

Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract Surgery

Cataracts

United States
University of British Columbia
Nike

Completed

Footwear Minimalism Study

Healthy Runners

Canada
Wills Eye

Completed

Pain Reduction With Topical Bromfenac Versus Artificial Tear After Intravitreal Injection.

Pain | Pain, Acute | Intravitreal Injection

United States, Canada
Cindy Hutnik
Glaucoma Research Society of Canada

Unknown

NSAID vs Steroid in Trabeculectomy Wound Management

Glaucoma
University of Michigan

Recruiting

Transcutaneous Vibro-Acoustic Therapy in Parkinson Disease

Parkinson Disease

United States
Mayo Clinic
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaborators

Enrolling by invitation

A Study to Assess Metabolic Bone Disease of Prematurity Using an Acoustic Method

Osteopenia | Metabolic Bone Disease | Neonatal Rickets

United States
University of Leipzig
Universitätsklinikum Leipzig

Completed

Non-invasive Liver Screening for Risk Assessment for Coronary Heart Disease (NILS-R-CHD)

Coronary Disease | Non-alcoholic Fatty Liver Disease | Elasticity Imaging Techniques

Germany
Arcispedale Santa Maria Nuova-IRCCS

Completed

Bromfenac Versus Dexamethasone After Cataract Surgery (BVD)

Inflammation Eye

Italy
Carolina Eyecare Physicians, LLC
Science in Vision; Imprimis Pharmaceuticals, Inc.

Completed

Prophylactic Treatment: Lessdrops™ vs Standard Drops Regimen

Cataract

United States
Assiut University

Completed

Predictive Power of Share Wave Fibro Scan in HCC After HCV Infection

Hepatocellular Carcinoma

Egypt
Universitätsklinikum Hamburg-Eppendorf
National Natural Science Foundation of China; German Research Foundation

Suspended

Crossmodal Learning in Therapeutic Processes (Task 2-1)

Stroke

Germany
Riphah International University

Recruiting

Kinesthetic Exercises and Sine Sound Waves in Cervical Spondylosis

Cervical Spondylosis

Pakistan

3

Subscribe